Encyclopedia of Global Bioethics

Living Edition
| Editors: Henk ten Have

Corruption

  • Jennifer E. Miller
Living reference work entry
DOI: https://doi.org/10.1007/978-3-319-05544-2_124-1

Abstract

This chapter discusses the nature and typology of corruption, including “conflicts of interest,” “regulatory and institutional capture,” the “revolving door” phenomena, and “gaming of systems.” It argues that incorporating an institutional corruption lens into the field of global bioethics would help advance the global bioethics discourse. The chapter concludes by reviewing key reform strategies – such as proscription, independent monitoring, incentive design mechanisms, transparency and disclosure initiatives, blinding, ethics education, deliberation and ethical persuasion – that may help mitigate specific instances of corruption and contribute to building institutional integrity and trustworthiness.

Keywords

Bioethics Corruption Institutional corruption Regulatory capture Conflicts of interest Revolving door Incentive design mechanisms Transparency initiatives Blinding reform strategies 
This is a preview of subscription content, log in to check access.

References

  1. Brody, H. (2007). Hooked: Ethics, the medical profession, and the pharmaceutical industry (pp. 238–239). Lanham: Rowman & Littlefield.Google Scholar
  2. Hampson, L. A., Agrawal, M., Joffe, S., Gross, C. P., Verter, J., & Emanuel, E. J. (2006). Patients’ views on financial conflicts of interest in cancer research trials. The New England Journal of Medicine, 355, 2330–2337.CrossRefGoogle Scholar
  3. Lessig, L. (2013). Foreword: ‘Institutional corruption’ defined. The Journal of Law, Medicine and Ethics, 41(3), 553–555.CrossRefGoogle Scholar
  4. Marks, J. H. (2014). Toward a systemic ethics of public–private partnerships related to food and health. Kennedy Institute of Ethics Journal, 24(3), 267–299.CrossRefGoogle Scholar
  5. Miller, J. E. (2013a). From bad pharma to good pharma: Aligning market forces with good and trustworthy practices through accreditation, certification, and rating. The Journal of Law, Medicine and Ethics, 41(3), 601–610.CrossRefGoogle Scholar
  6. Miller, J. E. (2013b). Bioethical accreditation or rating needed to restore trust in pharma. Nature Medicine, 19(3), 261.CrossRefGoogle Scholar
  7. Miller, J. E., & English, W. (2014). Corruption and bioethics. In H. A. M. J. ten Have & B. Gordijn (Eds.), Handbook of global bioethics (pp. 599–618). Amsterdam: Springer.CrossRefGoogle Scholar
  8. Robertson, C. T. (2013). Blinding as a solution to institutional corruption. (Edmond J. Safra Working Paper, No. 21).Google Scholar
  9. Salter, M. (2014). Crony capitalism, American style: What are we talking about here? (Harvard Business School Working Paper, No. 15–025).Google Scholar
  10. Sen, A., David Huffman, D., Loewenstein, G., Asch, D. A., Kullgren, J. T., & Volpp, K. (forthcoming). Do financial incentives reduce intrinsic motivation for weight loss? Evidence from two tests of crowding out. (Working Paper).Google Scholar
  11. Stiglitz, J. (2009). Regulation and failure. In D. Moss & J. Cisternino (Eds.), New perspectives on regulation. Cambridge, MA: The Tobin Project.Google Scholar
  12. Thompson, D. F. (2013). Two concepts of corruption. (Edmond J. Safra Working Papers, No. 16).Google Scholar
  13. Titmuss, R. M. (1997). In A. Oakley & J. Ashton (Eds.), The gift relationship: From human blood to social policy. New York: New Press.Google Scholar

Further Readings

  1. Moore, D., Tanlu, L., & Bazerman, M. H. (2010). Conflict of interest and the intrusion of bias. Judgment and Decision Making, 5(1), 37–53.Google Scholar
  2. Rose, R. L. (2013). Patient advocacy organizations: Institutional conflicts of interest, trust and trustworthiness. The Journal of Law, Medicine and Ethics, 41(3), 680–687.CrossRefGoogle Scholar
  3. Salter, M. (2010). Lawful but corrupt: Gaming and the problem of institutional corruption in the private sector. (Harvard Business School Working Paper, No. 11).Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2015

Authors and Affiliations

  1. 1.Department of Population HealthNYU Langone Medical CenterNew YorkUSA